Pet Dental Compositions with HMP and Ascorbic Acid

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preventing and treating dental calculus and gingivitis in animals are inadequate, particularly for pets like dogs and cats, as they often rely on periodic plaque removal and crystal growth inhibitors, which are not entirely effective.

Innovation Solution

Dental compositions combining hexametaphosphate (HMP) with ascorbic acid and beta glucans are developed, which can be incorporated into pet chews or edible articles to effectively treat and prevent gingivitis and dental calculus.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If periodic plaque removal and crystal growth inhibitors are used, then some prevention of dental calculus is achieved, but the effectiveness is insufficient for treating gingivitis and calculus in animals

Engineering Contradiction:
Improveeffectiveness of calculus preventionVSAvoidcomplexity of treatment regimen
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent combines multiple active ingredients (ascorbic acid, hexametaphosphate, and beta glucans) into a single dental composition that can be administered through pet chews or edible articles. This merging of multiple therapeutic agents into one product increases reliability of treatment while simplifying the complexity of the treatment regimen for pet owners.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention uses a composite formulation containing ascorbic acid, hexametaphosphate, and beta glucans together in a dental composition. This composite material approach allows synergistic effects of different compounds to work together, improving the overall effectiveness of calculus prevention and gingivitis treatment beyond what single ingredients could achieve alone.

Inventive Principle:
Principle #40Composite materials

2Reliability

If ascorbic acid, HMP, and beta glucans are combined in dental compositions, then effectiveness against gingivitis and calculus is significantly improved, but the formulation complexity increases

Engineering Contradiction:
Improveefficacy in reducing gingival and calculus scoresVSAvoidformulation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The dental composition is designed to perform multiple functions simultaneously: ascorbic acid provides antioxidant and anti-inflammatory effects, hexametaphosphate acts as a crystal growth inhibitor, and beta glucans contribute to immune support and plaque reduction. This multi-functionality approach allows one composition to address multiple aspects of oral health, improving efficacy while managing formulation complexity through intentional design.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent specifies optimized concentration ranges for each ingredient (ascorbic acid: 0.01-10%, HMP: 0.1-5%, beta glucans: 0.1-5%) to achieve therapeutic effectiveness. By carefully controlling these parameters, the formulation achieves high efficacy in reducing gingival and calculus scores while maintaining manageable formulation complexity through defined concentration specifications.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The dental compositions significantly reduce gingival, plaque, and calculus scores in animals, offering a more effective solution than existing methods by providing a combination of HMP, ascorbic acid, and beta glucans that inhibit calculus formation and treat existing conditions.

Implementation Method 1

periodic application of crystal growth inhibiting compounds that hinder the calcification of dental plaque by saliva

Methodology Applied
Scientific EffectCrystal growth inhibition:

Implementation Method 2

the dental compositions include ascorbic acid in combination with at least one of a hexametaphosphate (HMP) and a beta glucans

Methodology Applied
Scientific EffectAntioxidant effect:

Implementation Method 3

at least one beta glucans may be present in an amount ranging from greater than 0 to about 1.0 weight %

Methodology Applied
Scientific EffectImmune modulation:

Data Source

PatentUS9801800B2Compositions for improving the oral health of animals, methods using same, and pet treats incorporating the same
Publication Date: 2017.10.31 TFH PUBLICATIONS INC
  • US9801800B2 patent drawing
  • US9801800B2 patent drawing
  • US9801800B2 patent drawing

AI summary

Described herein are dental compositions, articles of manufacture including such dental compositions, and methods of using such dental compositions. In some embodiments, the dental compositions include a combination of ascorbic acid with at least one of a hexametaphosphate and a beta glucans. In some instances, the dental compositions are included within an edible article, a chew, or an edible chew. Administration of the dental compositions to the oral cavity of a subject may reduce the gingival, plaque, and/or calculus scores of the subject over a defined time period.